InnoCore Pharmaceuticals Attends the CPHI Frankfurt – Discover Advanced Long-Acting Injectable Technologies

InnoCore Pharmaceuticals is excited to join the CPHI in Frankfurt, one of the world’s leading pharmaceutical networking events. Join us to explore how our SynBiosys® platform is transforming the development of biodegradable long-acting injectables for peptides, proteins, and other biologics.

Reducing dosing frequencies

Vincent de Boer, Business Development Manager, will be available to discuss:

• Our bespoke tailored sustained-release formulations
• How we overcome the PLGA limitations such as aggregation, acylation, and high local pH
• How we achieve sustained release profiles from one week to several months
• Collaborative development from early-stage R&D to clinical supply

Meet at the CPHI!

Connect with Vincent to learn more about our innovative drug delivery solutions and explore partnership opportunities.

Whether you’re looking to extend dosing intervals, improve patient compliance, or transition from IV to subcutaneous delivery, InnoCore offers proven expertise and tailored solutions to meet your formulation needs.

Let’s connect at CPHI Frankfurt and shape the future of injectable therapeutics together.